[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,759,498
  • Shares Outstanding, K 22,414
  • Annual Sales, $ 883,370 K
  • Annual Income, $ 78,340 K
  • EBIT $ 203 M
  • EBITDA $ 294 M
  • 60-Month Beta 0.44
  • Price/Sales 2.02
  • Price/Cash Flow 8.01
  • Price/Book 3.31

Options Overview Details

View History
  • Implied Volatility 53.88% (-1.50%)
  • Historical Volatility 29.50%
  • IV Percentile 89%
  • IV Rank 51.83%
  • IV High 73.85% on 07/24/25
  • IV Low 32.40% on 09/22/25
  • Expected Move (DTE 15) 3.06 (3.92%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 8
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 10.30
  • Today's Open Interest 2,385
  • Open Int (30-Day) 5,162
  • Expected Range 74.91 to 81.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.95
  • Number of Estimates 4
  • High Estimate $1.07
  • Low Estimate $0.77
  • Prior Year $1.37
  • Growth Rate Est. (year over year) -30.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.02 +6.78%
on 03/30/26
82.43 -5.40%
on 04/20/26
+5.15 (+7.07%)
since 03/27/26
3-Month
70.15 +11.15%
on 03/13/26
83.80 -6.96%
on 02/05/26
-4.03 (-4.91%)
since 01/29/26
52-Week
56.71 +37.49%
on 05/23/25
99.50 -21.64%
on 09/10/25
+7.21 (+10.19%)
since 04/29/25

Most Recent Stories

More News
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its first quarter 2026 financial results...

ANIP : 77.97 (-0.68%)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

PRINCETON, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pimozide Tablets 1 mg and 2 mg. ANI’s Pimozide Tablets...

ANIP : 77.97 (-0.68%)
1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges

1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges

ANIP : 77.97 (-0.68%)
SNX : 224.04 (+0.31%)
EVER : 15.76 (-2.48%)
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

PRINCETON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg...

ANIP : 77.97 (-0.68%)
1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down

1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down

EBC : 19.89 (-1.24%)
NOG : 27.95 (+1.42%)
ANIP : 77.97 (-0.68%)
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration...

ANIP : 77.97 (-0.68%)
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know

Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know

PRVA : 24.69 (-0.60%)
ANIP : 77.97 (-0.68%)
AORT : 34.64 (-4.65%)
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving...

ANIP : 77.97 (-0.68%)
3 Russell 2000 Stocks We Steer Clear Of

3 Russell 2000 Stocks We Steer Clear Of

SMPL : 13.59 (-1.45%)
OBK : 46.91 (-0.93%)
ANIP : 77.97 (-0.68%)
3 Reasons ANIP is Risky and 1 Stock to Buy Instead

3 Reasons ANIP is Risky and 1 Stock to Buy Instead

ANIP : 77.97 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 80.09
2nd Resistance Point 79.33
1st Resistance Point 78.65
Last Price 77.97
1st Support Level 77.21
2nd Support Level 76.45
3rd Support Level 75.77

See More

52-Week High 99.50
Fibonacci 61.8% 83.15
Fibonacci 50% 78.10
Last Price 77.97
Fibonacci 38.2% 73.06
52-Week Low 56.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.